May 7, 2020 Cellectar Reports First Quarter 2020 Financial Results and Provides a Corporate Update Learn More
Mar 9, 2020 Cellectar Reports Financial Results for Year Ended December 31, 2019 and Provides a Corporate Update Learn More
Feb 19, 2020 Cellectar Biosciences Announces CLR 131 Achieves Primary Efficacy Endpoints from Its Phase 2 CLOVER-1 Study in Relapsed/Refractory B-cell Lymphomas and Completion of the Phase 1 Relapsed/Refractory Multiple Myeloma Dose Escalation Study Learn More